The first Vertex Pharmaceuticals trade was made in Q3 2016.
Since then Jeremy Grantham bought shares five more times and sold shares on six occasions. The investor completely sold their stake between Q1 2023 and Q3 2023.
Avg closing price
Price range
Sold -58.5 Thousand shares
Q3 2023
Avg closing price
$349.73
Price range
$338.18
-
$362.46
Sold 39.0% shares (-37.4 Thousand shares)
Q2 2023
Avg closing price
$336.94
Price range
$314.42
-
$351.91
Sold 18.2% shares (-21.3 Thousand shares)
Q1 2023
Avg closing price
$299.93
Price range
$283.23
-
$323.10
Increased shares by 3.7% (+4.2 Thousand shares)
Q4 2022
Avg closing price
$304.77
Price range
$285.76
-
$321.48
Sold 0.4% shares (-500 shares)
Q3 2022
Avg closing price
$287.72
Price range
$273.83
-
$305.53
Increased shares by 38.2% (+31.4 Thousand shares)
Q2 2022
Avg closing price
$267.66
Price range
$234.96
-
$292.55
New holding (+82.1 Thousand shares)
Q1 2022
Avg closing price
$237.33
Price range
$221.42
-
$260.97
Sold -3.2 Thousand shares
Q2 2019
Avg closing price
$174.82
Price range
$164.61
-
$190.37
New holding (+3.2 Thousand shares)
Q4 2018
Avg closing price
$173.27
Price range
$151.91
-
$192.21
Sold -100 Thousand shares
Q1 2017
Avg closing price
$88.04
Price range
$74.89
-
$109.35
Increased shares by 98.8% (+49.7 Thousand shares)
Q4 2016